BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11204312)

  • 1. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
    Hilger E; Kasper S
    Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Danileviciūte V
    Medicina (Kaunas); 2002; 38(11):1057-65. PubMed ID: 12532717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia.
    Kapur S; Remington G
    Annu Rev Med; 2001; 52():503-17. PubMed ID: 11160792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
    Möller HJ
    Nervenarzt; 2000 May; 71(5):345-53. PubMed ID: 10846709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Atypical antipsychotics].
    Naber D
    Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
    [No Abstract]   [Full Text] [Related]  

  • 6. The value of atypical antipsychotics in the treatment of schizophrenia.
    Jessen LM
    Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological approaches to the management of schizophrenia.
    Lambert TJ; Castle DJ
    Med J Aust; 2003 May; 178(S9):S57-61. PubMed ID: 12720524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
    Geddes J; Freemantle N; Harrison P; Bebbington P
    BMJ; 2000 Dec; 321(7273):1371-6. PubMed ID: 11099280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics and weight gain--a systematic review.
    Taylor DM; McAskill R
    Acta Psychiatr Scand; 2000 Jun; 101(6):416-32. PubMed ID: 10868465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotropics and weight gain].
    Sahli Ch; Bryois Ch
    Praxis (Bern 1994); 2004 Aug; 93(35):1393-401. PubMed ID: 15468580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New antipsychotic agents].
    Olie JP; Ghaoui S; Bayle FJ
    Encephale; 1999 Nov; 25 Spec No 3():52-60. PubMed ID: 10598295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study.
    Bobes J; Garc A-Portilla MP; Rejas J; Hern Ndez G; Garcia-Garcia M; Rico-Villademoros F; Porras A
    J Sex Marital Ther; 2003; 29(2):125-47. PubMed ID: 12623765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current pharmacotherapy of schizophrenia].
    Bitter I
    Orv Hetil; 2004 Jan; 145(3):105-9. PubMed ID: 15027331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.
    Kasper S; Hale A; Azorin JM; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 2():II1-II14. PubMed ID: 10603070
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
    Leucht S; Pitschel-Walz G; Abraham D; Kissling W
    Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new atypical antipsychotics: advantages and disadvantages.
    Lemon MD
    S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing the side effect profile of the atypical antipsychotics.
    Alao AO; Malhotra K; Dewan MJ
    West Afr J Med; 2002; 21(4):313-5. PubMed ID: 12665274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.